Effects of fibrinogen and platelet transfusion on coagulation and platelet function in bleeding cardiac surgery patients

被引:15
|
作者
Hakimi, Caroline Shams [1 ]
Singh, Sukhi [1 ]
Hesse, Camilla [2 ]
Jeppsson, Anders [1 ,3 ]
机构
[1] Univ Gothenburg, Sahlgrenska Acad, Inst Med, Dept Mol & Clin Med, Gothenburg, Sweden
[2] Univ Gothenburg, Sahlgrenska Acad, Inst Biomed, Dept Clin Chem & Transfus Med, Gothenburg, Sweden
[3] Sahlgrens Univ Hosp, Dept Cardiothorac Surg, Gothenburg, Sweden
关键词
CLOT FORMATION; BLOOD-SAMPLES; CONCENTRATE; THROMBOELASTOMETRY; SUPPLEMENTATION; AGGREGOMETRY; AGGREGATION; CLOPIDOGREL; REVERSAL; BYPASS;
D O I
10.1111/aas.13295
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Background Excessive bleeding is a significant problem in cardiac surgery. Fibrinogen and platelet concentrate transfusion are used clinically to improve haemostasis and reduce bleeding but little is known about their functional effects on coagulation and platelet function in patients with ongoing bleeding. Methods Forty-two patients with ongoing bleeding after cardiac surgery were included in an observational study. Patients received either fibrinogen concentrate (n = 16), platelet concentrate (n = 12), or both fibrinogen and platelets (n = 14), median doses 2 g fibrinogen and 2 units platelets given at one occasion. Blood samples were collected before and after transfusion. Coagulation (clotting time and clot stability) was analysed with rotational thromboelastometry, and platelet function with impedance aggregometry. In addition, platelet count and fibrinogen concentration was measured. Chest drain output was measured before and after the transfusion. Results Fibrinogen infusion resulted in an increase in fibrinogen concentration and clot stability (P = 0.001), but had no effect on platelet aggregation. Platelet transfusion did not significantly affect coagulation, but improved arachidonic acid- and TRAP-induced platelet aggregation (P = 0.017 and 0.034 respectively) and increased platelet count. Combined fibrinogen and platelet transfusion shortened clotting time (P = 0.005) and increased clot stability (P = 0.001), and improved arachidonic acid- and TRAP-induced platelet aggregation (P = 0.004 and 0.016 respectively), and increased fibrinogen concentration and platelet count. The median bleeding volume was 150 (25th-75th percentile 70-240) mL/h before, and 60 (40-110) mL/h after transfusion of fibrinogen and/or platelet concentrate (P < 0.001). Conclusion The results demonstrate improved coagulation and platelet function following fibrinogen and platelet transfusion in patients bleeding after cardiac surgery.
引用
收藏
页码:475 / 482
页数:8
相关论文
共 50 条
  • [1] Prophylactic Fibrinogen Infusion in Cardiac Surgery Patients: Effects on Biomarkers of Coagulation, Fibrinolysis, and Platelet Function
    Karlsson, Martin
    Ternstrom, Lisa
    Hyllner, Monica
    Baghaei, Fariba
    Skrtic, Stanko
    Jeppsson, Anders
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2011, 17 (04) : 396 - 404
  • [2] Restoration of platelet function with platelet transfusion in cardiac surgery patients on dual antiplatelet therapy
    O'Connor, S.
    Rejane, M.
    Amour, J.
    Abtan, J.
    Kerneis, M.
    Silvain, J.
    Brugier, D.
    Leprince, P.
    Montalescot, G.
    Collet, J. P.
    EUROPEAN HEART JOURNAL, 2013, 34 : 889 - 889
  • [3] Could the combination of bleeding time and platelet function predict the perioperative transfusion requirements in cardiac surgery patients?
    M Kataphigioti
    D Karamichaleli
    M Kounavi
    E Iliopoulou
    G Palatianos
    E Melissari
    Critical Care, 11 (Suppl 2):
  • [4] Extended platelet transfusion in bleeding patients with platelet transfusion refractoriness
    Fernandez-Barge, Tatiana
    Dominguez-Garcia, Juan J.
    Diaz-Santander, Alba
    Rivero-Fernandez, Raquel
    Cantera-Estefania, Rodrigo
    Mendez, Gala A.
    Romon, Inigo
    TRANSFUSION AND APHERESIS SCIENCE, 2023, 62 (04)
  • [5] Platelet function analysed by ROTEM platelet in cardiac surgery after cardiopulmonary bypass and platelet transfusion
    Kjellberg, Gunilla
    Holm, Manne
    Lindvall, Gabriella
    Gryfelt, Gunilla
    Linden, Jan
    Wikman, Agneta
    TRANSFUSION MEDICINE, 2020, 30 (05) : 369 - 376
  • [6] Platelet fibrinogen in the patients with idiopathic bleeding platelet disorder
    Linhua Y.
    Di S.
    Ailian W.
    Wenning W.
    Zhongping L.
    Rui Y.
    Yan Y.
    Yujin Z.
    Current Medical Science, 2000, 20 (2) : 134 - 136
  • [7] Optimizing transfusion in cardiac surgery: Deleterious effects of platelet transfusion
    Desai, Nimesh D.
    Cohen, Gideon
    Nesher, Nahum
    Sever, Jeri Y.
    Christakis, George T.
    Goldman, Bernard S.
    Fremes, Stephen E.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 49 (09) : 304A - 304A
  • [8] Platelet concentrates transfusion in cardiac surgery and platelet function assessment by multiple electrode aggregometry
    Rahe-Meyer, N.
    Winterhalter, M.
    Boden, A.
    Froemke, C.
    Piepenbrock, S.
    Calatzis, A.
    Solomon, C.
    ACTA ANAESTHESIOLOGICA SCANDINAVICA, 2009, 53 (02) : 168 - 175
  • [9] Antiplatelet Therapy, Platelet Function Testing, and Bleeding Complications in Cardiac Surgery Patients
    Hansson, Emma C.
    Jeppsson, Anders
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2017, 43 (07): : 699 - 705
  • [10] Effects of fibrinogen and platelet supplementation on clot formation and platelet aggregation in blood samples from cardiac surgery patients
    Hakimi, Caroline Shams
    Blixter, Inger Fagerberg
    Hansson, Emma C.
    Hesse, Camilla
    Wallen, Hakan
    Jeppsson, Anders
    THROMBOSIS RESEARCH, 2014, 134 (04) : 895 - 900